Skip to main content
Clinical Trials/NL-OMON53316
NL-OMON53316
Recruiting
Not Applicable

ongitudinal Early Epilepsy Study - LEES

Medisch Universitair Ziekenhuis Maastricht0 sites75 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
75
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • 1\. Primarily presented with daily occurring episodes of brief loss of
  • consciousness (absences) in an otherwise normal child in the previous 2 years.
  • 2\. An EEG showing 3 Hz (2\.5\-4\.5 Hz) generalized rythmic spike\-and\-wave
  • complexes with a discharge duration of at least 3 seconds on a present or
  • former EEG.
  • 3\. Early absence epilepsy , defined as a confirmed diagnosis or seizures within
  • 4\. Aged 6\-12 years at inclusion
  • 5\. Permitted accompanying factors:
  • \- A few generalized tonic\-clonic seizures (assessed individually according to
  • ILAE statements);

Exclusion Criteria

  • \* A diagnosis according to ILAE criteria of the following epilepsy syndromes:
  • Juvenile Absence Epilepsy; Eylide myoclonia with absences; Dravet syndrome;
  • Epilepsy with myoclonic\-atonic seizures; Epilepsy with Myoclonic Absences;
  • Lennox\-Gastaut syndrome; Frontal Lobe Epilepsy or other focal epilepsy.
  • \* A confirmed diagnosis of epilepsy/seizures for more than 2 years (58\).
  • \* Recent hospitalizations in the last months or a history which might limit
  • participation in or completion of the study protocol.
  • \* Behavioural characteristics which might hamper the gathering of useful MRI
  • \* Intellectual disability or other diseases/causes that may underlie cognitive
  • impairment (i.e. neurodegenerative diseases).

Outcomes

Primary Outcomes

Not specified

Similar Trials